BioPharma Resources

Drug Trial Radar · NCT07334080

ECC4703 Food Effect and Relative Bioavailability Study in Healthy Adult Participants

A Phase I, Open-Label, Randomized, Single-Dose, Crossover Study to Evaluate Food Effect and Relative Bioavailability of ECC4703 Formulations (F0, F1, F2, and F3) in Healthy Adults

Last checked: Nov 19, 2026Latest source record: Sep 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

72

Planned (sponsor's estimate)

Start

Jan 7, 2026

Primary completion

Apr 2027

Study completion Apr 2027

Sponsor

Lead sponsor
EccogeneIndustry
Sponsor type
Industry
First posted
Jan 12, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a Phase I, open-label, randomized, single-dose, 2-part study designed to evaluate the food effect and relative bioavailability of ECC4703 in healthy adult participants.

Conditions

  • Metabolic Dysfunction-Associated Steatohepatitis

Interventions

  • ECC4703 F0 formulationDrug

    A single dose of ECC4703 F0

  • ECC4703 F1 formulationDrug

    A single dose of ECC4703 F1

  • ECC4703 F2 formulationDrug

    A single dose of ECC4703 F2

  • ECC4703 F3 formulationDrug

    A single dose of ECC4703 F3

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. ECC4703 pharmacokinetic (PK) parameters AUC0-tlastTime frame: Up to Day 13
  2. ECC4703 PK parameters AUC0-infTime frame: Up to Day 13
  3. ECC4703 PK parameters CmaxTime frame: Up to Day 13
  4. ECC4703 PK parameters tmaxTime frame: Up to Day 13
  5. ECC4703 PK parameters AUC0-tTime frame: Up to Day 13
  6. ECC4703 PK parameters AUC0-24Time frame: Up to Day 13
  7. ECC4703 PK parameters AUCextrTime frame: Up to Day 13
  8. ECC4703 PK parameters tlagTime frame: Up to Day 13
  9. ECC4703 PK parameters t1/2Time frame: Up to Day 13
  10. ECC4703 PK parameters CL/FTime frame: Up to Day 13

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • CMAX Clinical Research Pty Ltd

    Adelaide, South Australia, Australia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.